Journal Club - Recent Additions

May - 2019

Next    

Showing Journal 1 of 9


Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy- The SCARLET Randomized Clinical Trial

JL Vincent, B Francois, I Zabolotskikh et al for The Scarlet Study Group JAMA, 2019, online first May 2019

Comment

Does administration of a recombinant human soluble thrombomodulin reduce mortality of critically ill patients with sepsis-associated coagulopathy?

The rationale behind asking this question;

  • Sepsis-associated coagulopathy, defined as prolonged INR and reduced...

May



Previous Comments

No Comments yet.